Fondazione Policlinico Universitario Agostino Gemelli

Study Description

TRACER RT is an interventional study introducing a new operational model for the monitoring and early diagnosis of COVID-19 infection in healthcare professionals and patients during multimodal therapies and the follow-up period through the use of Healthentia as a dedicated App and wearable technologies. The primary aim is to introduce Oncology patients with the use of portable monitoring systems such as Patient Reported Experience Measures (PREMs) and Patient-Reported Outcome Measures (PROMs) by means of a dedicated app and even a tracking device as Electronic Health Record data harvesting devices, during their multimodal therapies and follow-up period.


"Monitoring patients during multimodal therapies or during special situations such as SARS-COV-2 infection, may represent a significant step towards a comprehensive and reliable therapy approach, quality of life assessment, prevention of complications before its clinical onset and clinical outcomes prediction."

Study Design & Methods

The application will be used by patients during radiotherapy (RT) or in the first phase of follow-up and healthcare workers of the RT division, with the aim of monitoring the earlier symptoms of SARS-COV-2 infection. After the SARS-COV-2 emergency the app will be used to monitor patients during and after radiotherapy with a special focus on supportive care and oncological rehabilitation.
Daily, weekly and monthly questionnaires are collecting data to be assessed by Healthentia and alert low or high risk of a Covid-19 infection.

Study Details

Type: Interventional

Disease: Covid19 Surveillance of Oncology patients and Hospital personnel

Site: Fondazione Policlinico Gemelli

Start: March 2020

Population: Incoming patients and personnel

Duration: Ongoing

Reduce risk of Infection in the Radiotherapy Department.

Oncology patients and Hospital personnel surveillance for COVID-19 Symptom appearance